All three patients with HPV DNA and p16-overexpressing tumours, defined as HPV-positive tumours, presented with early-stage disease upon diagnosis (Table 2); the treatment and clinical outcome, however, varied, as described below:. Here, CDKN2A is linked to neoplasm.